Biogen Idec Inc. (NASDAQ: BIIB) will continue on its present course as an independent company after BIIB's Board of Directors completed a review of strategic alternatives to maximize shareholder value:
BIIB recently traded at $56.60 in after market trading, below its close of $75.88. BIIB December straddle went out at $6.35. BIIB January option implied volatility of 55 is above its 26-week average of 37 according to Track Data, suggesting options traders expected movement.
Daily Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.
Five winners of a weak dollar
For a quick-read on the U.S. economy, check the price of gasoline
Closing Bell: What Friday 13th curse? (ANF, BA, GENZ, DIS, PALM, PLA)
